Development of hirudin as an antithrombotic agent.
Markwardt
F
F
Institute for Pharmacology and Toxicology, Medizinische Akademie Erfurt, DDR.
D000595:Amino Acid Sequence; D000818:Animals; D000925:Anticoagulants / Q000627:therapeutic use; D003328:Coronary Thrombosis / Q000517:prevention & control; D024764:Hirudin Therapy; D006629:Hirudins / Q000494:pharmacology; D006801:Humans; D008969:Molecular Sequence Data; D011994:Recombinant Proteins / Q000494:pharmacology / Q000627:therapeutic use; D006435:Renal Dialysis; D013917:Thrombin / Q000037:antagonists & inhibitors; D013927:Thrombosis / Q000188:drug therapy*
D000925:Anticoagulants; D006629:Hirudins; D011994:Recombinant Proteins; D013917:Thrombin